Redmile Group, LLC — 13F Holdings

2026 Q3  ·  45 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Redmile Group, LLC maintained a portfolio of 45 distinct positions. The most significant new addition was ELECTRA THERAPEUTICS INC, now representing 4.47% of the total fund value. They heavily accumulated shares in NURIX THERAPEUTICS INC, increasing the position by 93.9%. The fund also reduced its exposure to SCHOLAR ROCK HLDG CORP by 29.6%.
Position History hover any row below to update
Loading…
Redmile Group, LLC San Francisco, CA Hedge Fund AUM $1,366M
PCA Score Concentration Risk
Risk ENB
Total Positions
45
Quarter
2026 Q3
Top Holding
NRIX (13.7%)
Top 10 Concentration
71.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-45 of 45

Redmile Group, LLC Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
NRIX
NURIX THERAPEUT...
Healthcare 13.71% 6.64% #1 4
Prev: #5
9.0
—
3,827,298 93.9%
P
S
7,901,085 $187,334,725 2020 Q3 13F Filing 2026-09-30 2026-11-16
KRYS
KRYSTAL BIOTECH...
Healthcare 12.84% 15.77% #2
Prev: #2
6.0
—
-104,321 -16.5%
P
S
527,684 $175,486,591 2018 Q4 13F Filing 2026-09-30 2026-11-16
SRRK
SCHOLAR ROCK HL...
Healthcare 10.73% 15.92% #3 2
Prev: #1
5.0
—
-1,277,130 -29.6%
P
S
3,033,962 $146,601,044 2018 Q2 13F Filing 2026-09-30 2026-11-16
STOK
STOKE THERAPEUT...
Healthcare 7.36% 8.67% #4 1
Prev: #3
3.9
—
-76,892 -1.9%
P
S
3,869,028 $100,594,728 2019 Q2 13F Filing 2026-09-30 2026-11-16
IMNM
IMMUNOME INC
Healthcare 6.87% 6.99% #5 1
Prev: #4
3.7
—
-548,526 -11.2%
P
S
4,363,064 $93,849,507 2023 Q4 13F Filing 2026-09-30 2026-11-16
ABSI
ABSCI CORPORATI...
Healthcare 5.26% 5.24% #6
Prev: #6
2.6
—
-68,298 -1.0%
P
S
6,671,377 $71,850,730 2021 Q3 13F Filing 2026-09-30 2026-11-16
ETRA
ELECTRA THERAPE...
Healthcare 4.47% — #7
Prev: #—
5.3
—
5,430,918 —
NEW
5,430,918 $61,097,828 2026 Q3 13F Filing 2026-09-30 2026-11-16
ANNX
ANNEXON INC
Healthcare 4.42% 4.55% #8 1
Prev: #7
4.3
—
2,408,198 20.3%
P
S
14,278,075 $60,396,257 2020 Q3 13F Filing 2026-09-30 2026-11-16
NGNE
NEUROGENE INC
Healthcare 3.18% 2.98% #9 1
Prev: #10
3.3
—
150,000 10.6%
P
S
1,562,199 $43,460,376 2023 Q4 13F Filing 2026-09-30 2026-11-16
RGNX
REGENXBIO INC
Healthcare 2.78% 3.51% #10 2
Prev: #8
3.1
—
679,698 15.6%
P
S
5,048,502 $38,015,220 2015 Q3 13F Filing 2026-09-30 2026-11-16
STTK
SHATTUCK LABS I...
Healthcare 2.54% 3.21% #11 2
Prev: #9
1.0
—
-1,805,043 -26.2%
P
S
5,086,990 $34,693,272 2020 Q4 13F Filing 2026-09-30 2026-11-16
FATE
FATE THERAPEUTI...
Healthcare 2.23% 2.33% #12 1
Prev: #13
1.9
—
no change no change
P
S
12,872,946 $30,508,882 2015 Q2 13F Filing 2026-09-30 2026-11-16
SLN
SILENCE THERAPE...
Healthcare 1.97% 1.60% #13 2
Prev: #15
2.8
—
296,117 13.7%
P
S
2,460,894 $26,897,571 2024 Q1 13F Filing 2026-09-30 2026-11-16
BEAM
BEAM THERAPEUTI...
Healthcare 1.90% 2.68% #14 3
Prev: #11
1.3
—
-102,477 -8.8%
P
S
1,061,782 $25,960,570 2020 Q1 13F Filing 2026-09-30 2026-11-16
N/A
ATTOVIA THERAPE...
Unknown 1.46% — #15
Prev: #—
4.1
—
1,163,587 —
NEW
1,163,587 $19,943,881 — 13F Filing 2026-09-30 2026-11-16
AGMB
AGOMAB THERAPEU...
Healthcare 1.41% 2.38% #16 4
Prev: #12
0.6
—
-993,696 -36.3%
P
S
1,740,230 $19,316,553 2026 Q1 13F Filing 2026-09-30 2026-11-16
NUVB
NUVATION BIO IN...
Healthcare 1.24% 1.16% #17 1
Prev: #18
1.5
—
no change no change
P
S
3,031,009 $16,973,650 2021 Q1 13F Filing 2026-09-30 2026-11-16
ADRX
ADARX PHARMACEU...
Healthcare 1.12% — #18
Prev: #—
3.9
—
769,345 —
NEW
769,345 $15,340,739 2026 Q3 13F Filing 2026-09-30 2026-11-16
IDYA
IDEAYA BIOSCIEN...
Healthcare 1.07% 1.60% #19 5
Prev: #14
0.4
—
-258,883 -40.4%
P
S
381,319 $14,650,276 2023 Q4 13F Filing 2026-09-30 2026-11-16
ADCT
ADC THERAPEUTIC...
Healthcare 1.03% 0.83% #20 5
Prev: #25
0.9
—
57,842 0.5%
P
S
11,584,552 $14,133,153 2020 Q2 13F Filing 2026-09-30 2026-11-16
SLDB
SOLID BIOSCIENC...
Healthcare 1.03% 1.31% #21 4
Prev: #17
0.9
—
-4,353 -0.2%
P
S
1,944,342 $14,057,593 2024 Q4 13F Filing 2026-09-30 2026-11-16
ZYME
ZYMEWORKS INC
Healthcare 0.95% 0.86% #22 2
Prev: #24
1.4
—
no change no change
P
S
491,654 $13,023,914 2022 Q4 13F Filing 2026-09-30 2026-11-16
OBX
OBSIDIAN THERAP...
Healthcare 0.84% — #23
Prev: #—
3.8
—
833,157 —
NEW
833,157 $11,439,246 2026 Q3 13F Filing 2026-09-30 2026-11-16
BMRN
BIOMARIN PHARMA...
Healthcare 0.83% 1.02% #24 2
Prev: #22
0.3
—
-75,631 -28.5%
P
S
189,538 $11,372,280 2007 Q4 13F Filing 2026-09-30 2026-11-16
CLYM
CLIMB BIO INC
Healthcare 0.82% 1.07% #25 5
Prev: #20
0.3
—
-251,841 -20.5%
P
S
974,489 $11,177,389 2026 Q2 13F Filing 2026-09-30 2026-11-16
CLDX
CELLDEX THERAPE...
Healthcare 0.76% 1.08% #26 7
Prev: #19
0.3
—
-112,151 -25.8%
P
S
321,770 $10,428,566 2020 Q2 13F Filing 2026-09-30 2026-11-16
ALXO
ALX ONCOLOGY HL...
Healthcare 0.73% 1.03% #27 6
Prev: #21
0.8
—
-207,241 -2.8%
P
S
7,185,263 $9,987,516 2020 Q3 13F Filing 2026-09-30 2026-11-16
AURA
AURA BIOSCIENCE...
Healthcare 0.71% 0.79% #28 2
Prev: #26
0.8
—
-114,188 -6.9%
P
S
1,552,479 $9,749,568 2026 Q2 13F Filing 2026-09-30 2026-11-16
COGT
COGENT BIOSCIEN...
Healthcare 0.70% 1.31% #29 13
Prev: #16
0.3
—
-206,715 -41.1%
P
S
296,606 $9,497,324 2023 Q2 13F Filing 2026-09-30 2026-11-16
CBLL
CERIBELL INC
Healthcare 0.69% 0.51% #30
Prev: #30
1.3
—
no change no change
P
S
386,786 $9,433,711 2024 Q4 13F Filing 2026-09-30 2026-11-16
ODTX
ODYSSEY THERAPE...
Healthcare 0.61% 0.53% #31 4
Prev: #27
0.7
—
-50,490 -11.9%
P
S
374,510 $8,321,612 2026 Q2 13F Filing 2026-09-30 2026-11-16
XENE
XENON PHARMACEU...
Healthcare 0.52% 0.93% #32 9
Prev: #23
0.7
—
-38,338 -16.7%
P
S
191,036 $7,104,629 2022 Q2 13F Filing 2026-09-30 2026-11-16
LIVN
LIVANOVA PLC
Healthcare 0.47% 0.51% #33 5
Prev: #28
0.7
—
-9,022 -9.7%
P
S
84,132 $6,436,098 2017 Q2 13F Filing 2026-09-30 2026-11-16
ATRA
ATARA BIOTHERAP...
Healthcare 0.40% 0.34% #34
Prev: #34
2.7
—
195,151 44.2%
P
S
636,852 $5,413,242 2024 Q2 13F Filing 2026-09-30 2026-11-16
INSM
INSMED INC
Healthcare 0.36% 0.37% #35 3
Prev: #32
0.6
—
-8,332 -16.3%
P
S
42,902 $4,896,834 2014 Q3 13F Filing 2026-09-30 2026-11-16
EPRX
EUPRAXIA PHARMA...
Healthcare 0.35% 0.27% #36 1
Prev: #35
0.6
—
-91,519 -15.0%
P
S
519,881 $4,730,917 2026 Q1 13F Filing 2026-09-30 2026-11-16
DBVT
DBV TECHNOLOGIE...
Healthcare 0.32% 0.45% #37 6
Prev: #31
0.6
—
-37,023 -9.0%
P
S
373,417 $4,391,384 2025 Q4 13F Filing 2026-09-30 2026-11-16
ORIC
ORIC PHARMACEUT...
Healthcare 0.29% 0.26% #38 2
Prev: #36
0.6
—
-69,193 -19.1%
P
S
292,817 $3,944,245 2025 Q4 13F Filing 2026-09-30 2026-11-16
N/A
TCGX ACQUISITIO...
Unknown 0.27% — #39
Prev: #—
3.6
—
299,860 —
NEW
299,860 $3,751,249 — 13F Filing 2026-09-30 2026-11-16
PRME
PRIME MEDICINE ...
Healthcare 0.26% 0.34% #40 7
Prev: #33
0.6
—
-242,772 -17.5%
P
S
1,146,860 $3,503,657 2022 Q4 13F Filing 2026-09-30 2026-11-16
IVVD
INVIVYD INC
Healthcare 0.15% 0.15% #41 3
Prev: #38
0.6
—
-312,439 -12.0%
P
S
2,285,320 $1,988,457 2021 Q3 13F Filing 2026-09-30 2026-11-16
OCUL
OCULAR THERAPEU...
Healthcare 0.14% — #42
Prev: #—
3.6
—
243,954 —
NEW
243,954 $1,871,127 2026 Q3 13F Filing 2026-09-30 2026-11-16
ARDX
ARDELYX INC
Healthcare 0.13% 0.22% #43 6
Prev: #37
0.6
—
-117,880 -18.4%
P
S
523,870 $1,791,635 2019 Q4 13F Filing 2026-09-30 2026-11-16
PLRX
PLIANT THERAPEU...
Healthcare 0.06% 0.06% #44 5
Prev: #39
1.0
—
no change no change
P
S
772,126 $833,896 2020 Q2 13F Filing 2026-09-30 2026-11-16
ESTA
ESTABLISHMENT L...
Healthcare 0.00% 0.51%
Sold All 😨
(Was: #29)
0.0
—
-88,964 -100.0%
CLOSED
— $— 2018 Q3 13F Filing 2026-09-30 2026-11-16
Showing 1-45 of 45 holdings

Unlock Full Redmile Group, LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →